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Abstract The substrate specificity of the thermophilic L-
glycosidase (lacS) from the archaeon Sulfolobus solfataricus
(SSLG), a member of the glycohydrolase family 1, has been
analysed at a molecular level using predictions from known
protein sequences and structures and through site-directed
mutagenesis. Three critical residues were identified and mutated
to create catalysts with altered and broadened specificities for
use in glycoside synthesis. The wild-type (WT) and mutated
sequences were expressed as recombinant fusion proteins in
Escherichia coli, with an added His6-tag to allow one-step
chromatographic purification. Consistent with side-chain orien-
tation towards OH-6, the single Met439CCys mutation
enhances D-xylosidase specificity 4.7-fold and decreases D-
fucosidase activity 2-fold without greatly altering its activity
towards other D-glycoside substrates. Glu432CCys and
Trp433CCys mutations directed towards OH-4 and -3,
respectively, more dramatically impair glucose (Glc), galactose
(Gal), fucose specificity than for other glycosides, resulting in
two glycosidases with greatly broadened substrate specificities.
These include the first examples of stereospecificity tailoring in
glycosidases (e.g. WTCW433C, kcat/KM (Gal):kcat/KM (man-
nose (Man)) = 29.4:1C1.2:1). The robustness and high utility of
these broad specificity SSLG mutants in parallel synthesis were
demonstrated by the formation of libraries of L-glycosides of
Glc, Gal, xylose, Man in one-pot preparations at 50‡C in the
presence of organic solvents, that could not be performed by
SSLG-WT. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Recent advances in the development of carbohydrate-based
therapeutics [1], and the limitations of present chemical syn-
thetic methods for producing oligosaccharides, have led to
more novel approaches to the synthesis of carbohydrates
and their conjugates [2]. One approach to this problem is to
carry out such syntheses using carbohydrate processing en-
zymes such as glycosyltransferases or glycosidases, as a val-
uable source of catalytic activity for the manipulation of un-
protected carbohydrates [3^7]. Glycosidases are simple,
robust, soluble enzymes, and in general have been preferred
for such glycosynthesis [8,9]. Although catalysis of the hydro-
lysis of glycoside bonds is normally observed, glycosidases
may be successfully used to synthesise glycosides through re-
verse hydrolysis (thermodynamic control) or transglycosyla-
tion (kinetic control with activated donors) strategies. Thus
far, improvements in glycosidase synthetic utility have largely
focused upon developing new strategies for increasing low
product yields [10], improving regioselectivity of transfer [11]
or characterising available glycosidases for novel activities [8].
For example, a major advance in improving yields has been
the development of the glycosynthase [10,12^17] by Withers
and co-workers. These nucleophile-less glycosidase mutants
are capable of glycosyl transfer in yields of up to 90% using
glycosyl £uoride donors but do not hydrolyse glycoside prod-
ucts and they illustrate well the bene¢ts of glycosidase engi-
neering for creating more synthetically useful catalysts.
An area of glycosidase engineering which has thus far been
largely neglected is the engineering of new substrate speci¢c-
ities (to the best of our knowledge only three examples of
glycosidase speci¢city alteration exist: 1000-fold increased fu-
cose (Fuc):galactose (Gal) speci¢city from gene-shu¥ing in-
duced alteration of six residues [18] ; 200-fold increase in glu-
cose (Glc):Fuc speci¢city from a single point mutation [19] ; 5-
fold increase in activity towards 6-phospho-L-Gal from a sin-
gle point mutation [20] ; for an excellent review of remaining
challenges in glycosidase engineering see [21]). Since the na-
ture of the parent carbohydrate to be coupled to a given ac-
ceptor may be determined in synthesis simply through appro-
priate choice of donor, it is largely the stereoselectivity of a
given glycosidase that we wish to exploit. An area of growing
interest is that of combinatorial biocatalysis [22,23] : the use of
enzyme catalysts in parallel reactions to provide arrays of
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related molecules. In particular, the importance of gaining
access to diverse arrays of glycoconjugates has recently been
highlighted [24]. However, although combinatorial chemistry
has revolutionised the approach to traditional chemical syn-
thesis, the development of combinatorial biocatalysis has been
hampered by the often stringent substrate speci¢cities of syn-
thetically useful enzymes. As a solution to these problems we
have set ourselves the goal of (a) creating glycosidases with
the ability to process a broad range of glycosides while main-
taining their excellent stereoselectivity in glycoside bond for-
mation; (b) retuning the speci¢city of glycosidases in alterna-
tive directions.
To this end, we have probed the binding domain of the
thermophilic, retaining, exo-L-glycosidase, from Sulfolobus
solfataricus (SSLG, EC 3.2.1.23) using site-directed mutagen-
esis. The gene encoding this enzyme was originally isolated
and sequenced from the S. solfataricus strain MT4 [25] and
is classi¢ed as a member of the glycosyl hydrolase family 1
[26]. This robust, thermophilic enzyme is ideal as it has been
routinely expressed in Escherichia coli [27], characterised in
terms of its properties [28,29], activity and binding speci¢city
[30], has shown initial utility in synthesis [15] and its three-
dimensional (3D) structure, a classic (K/L)8 TIM [31] barrel
containing a radial active site channel in a kink of the ¢fth K/L
repeat, is known [32]. Substrate speci¢city in this enzyme has
been associated with two residues in the binding site, gluta-
mate 432 and methionine 439 which are largely conserved
across family 1 glycosyl hydrolases (Fig. 2). For example,
E432 (SSLG numbering) has been suggested to be responsible
for the rejection of 6-phosphoglycosides and glycosides of
glucuronic and galacturonic acid as substrates by the enzyme,
due to repulsive charge interactions [32]. Importantly, those
family 1 hydrolases in which these residues di¡er also show
altered substrate speci¢cities (vide infra). It follows therefore
that alteration of these residues and others in SSLG might
result in mutants that will accommodate di¡ering substrates.
With this rationale in mind, we have analysed the structure of
SSLG and created point mutants in which key residues impli-
cated in speci¢city determination have been tailored. This re-
sults in robust mutant enzymes with altered substrate specif-
icities and enhanced synthetic utility.
2. Materials and methods
2.1. Reagents, enzymes and bacterial strains
The wild-type (WT) sequence, lacS, encoding SSLG, was ampli¢ed
by PCR from Sulfolobus genomic DNA, using the following primers:
5P : CCATGGGACACCACCACCACCACCACCACTCATTAC; 3P :
CTCGAGTTAGTGCCTTTATGGCTTTACTGGAGGTAC.
The 5P primer introduced an N-terminal NcoI site and a 6U His-tag
immediately following the ATG initiation codon. The 3P primer in-
troduced a XhoI site after the stop codon. The PCR product was
cloned into pCR2.1 (Invitrogen) and individual clones were sequenced
to verify that no errors had been introduced.
Electrocompetent E. coli strain BL21(DE3) and His-bind nickel
resin were obtained from Novagen. 4-Methylumbelliferyl (4-MU) L-
D-glycoside substrates were purchased from Sigma. Pfu-turbo DNA
polymerase was obtained from Stratagene and NcoI, XhoI restriction
endonucleases, T4 DNA ligase from Promega, UK. Oligonucleotide
primers were obtained from MWG BioTech GmbH and Cruachem
Ltd. DNA sequencing was carried out by the DNA Sequencing Ser-
vice, Department of Biological Sciences, Durham, UK, using standard
protocols on Applied Biosystems DNA Sequencers.
2.2. Construction, selection and screening of the single point mutants
Mutations were introduced into the lacS gene coding sequence (in
pCR2.1) according to the Stratagene QuickChange mutagenesis
system, using the supplier’s protocol. Oligonucleotide primers used
for the generation of the point mutations were: for Glu432CCys,
5P-TCTAGCTGATAATTACTGTTGGGCTTCAGGATTCT-3P ; for
Trp433CCys, 5P-CTAGCTGATAATTACGAATGTGCTTCAGG-
ATTCTC-3P ; for Met439CCys, 5P-GCTTCAGGATTCTCTTGTA-
GGTTTGGTCTG-3P along with the corresponding complementary
primers. Individual point mutations were veri¢ed by DNA sequence
analysis. WT and mutated coding sequences were cloned into the
NcoI/XhoI sites of expression vector pET-24-d(+) (Novagen) and
transformed into E. coli BL21(DE3). Putative transformants were
identi¢ed by colony PCR using the SSLG coding sequence primers.
Selected clones were checked by DNA sequencing to con¢rm the
mutation, and the absence of unintended PCR-introduced base
changes.
2.3. Overexpression and puri¢cation of the His6-tagged mutant enzymes
Selected clones were grown in LB medium containing kanamycin
(50 Wg/ml), at 37‡C to an optical density of 0.6 at 600 nm, and the
target were proteins induced by the addition of 0.1 M IPTG. Cells
were harvested by centrifugation, resuspended in 1/10 volume of col-
umn loading bu¡er (5 mM imidazole, 20 mM Tris, 0.5 M NaCl, pH
7.8), and lysed using a Soniprep 150 Sonicator. The suspension was
recentrifuged to pellet cell debris (10 000 rpm, 30 min), and the His6-
tagged recombinant proteins were puri¢ed from the supernatant using
Ni-chelation chromatography (wash bu¡er: 60 mM imidazole, 20 mM
Tris, 0.5 M NaCl, pH 7.8; elution bu¡er: 300 mM imidazole, 20 mM
Tris, 0.5 M NaCl, pH 7.8). The eluted protein peak was dialysed
against 50 mM sodium phosphate bu¡er (pH 6.5), and stored at
4‡C. Protein concentration was quanti¢ed by the method of Bradford
[33] (reagents from Bio-Rad, The Netherlands). Puri¢ed proteins were
analysed by sodium dodecyl sulphate^polyacrylamide gel electropho-
resis (SDS^PAGE), gel ¢ltration chromatography and ESMS (Micro-
mass LCT, þ 8 Da).
2.4. Characterisation of the kinetic properties of enzymes
Parameters were determined by the method of initial rates. Activity
was measured in time course assays of the hydrolysis of 4-MU L-D-
glycosides (L-D-gluco, L-D-galacto, L-D-fuco, L-D-manno, L-D-xylo, L-
D-glucurono) at 5^15 concentrations (0.001^1.5 mM) incubated at
80‡C in 50 mM sodium phosphate bu¡er, pH 6.5. Reactions were
terminated at 2, 5, 10 and 15 min by the addition of 100 Wl of ice
cold 1 M Na2CO3, pH 10 and analysed (Labsystems Fluoroscan
Ascent plate reader, excitation 460 nm, emission 355 nm). KM and
kcat were derived by ¢tting the initial rates to Michaelis^Menten
curves using GraFit 4 (Erithacus Software Ltd., Staines, UK).
2.5. Sequence analysis
Sequence alignment was performed using ClustalW based on a
BLOSUM42 matrix. Enzymes of interest were determined by their
sequence similarity using PSI-BLAST searches of SwissProt and
TREMBL to BGAL_SULSO (SSLG) [25], including Pyrococcus fu-
riosus L-glucosidase (CelB) [34] used for molecular mechanics analysis.
In this way several glycosidases were also identi¢ed with both altered
substrate speci¢city and di¡erences in the residues occupying positions
432, 433 and 439 (SSLG numbering): Dalbergia cochinchinensis dal-
cochinin-8P-O-L-glucoside L-glucosidase [35]; Costus speciosus furosta-
nol-26-O-L-glycoside hydrolase [36]; LPH_HUMAN, human lactase
phlorizin hydrolase [37] ; MY3_SINAL, myrosinase from Sinapis alba
[38] ; LACG_STAAU (6-PBG), Staphylococcus aureus 6-phosphoga-
lactosidase [39].
2.6. Molecular mechanics and docking analysis
The X-ray structure of SSLG (RCSB-PDB entry 1gow) was used as
the starting point for calculations. The enzyme setup was performed
with Insight II, version 2.3.0 (Accelerys Inc., San Diego, CA, USA).
To create initial coordinates for the minimisation, hydrogens were
added at the pH used for kinetic measurements (6.5). The model
system was solvated with a 5 Aî layer of water molecules. Energy
simulations were performed with the DISCOVER module within Cer-
ius2, Version 3.8 on a Silicon Graphics Indigo computer, using the
consistent valence force ¢eld function. A non-bonded cuto¡ distance
of 18 Aî with a switching distance of 2 Aî was employed. The non-
bonded pair list was updated every 20 cycles and a dielectric constant
of 1 was used in all calculations. Docked structures were generated
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using the Builder module, and aligned within the active site using
appropriate bump, hydrogen bonding and docking interaction mon-
itors. The enzyme was then minimised in stages, with initially only the
water molecules being allowed to move, followed by water molecules
and the amino acid side chains, and then ¢nally the entire enzyme.
The L-D-Glcp was free to move throughout all stages of the minimi-
sation. Each stage of energy minimisation was conducted by means of
the method of steepest descends without Morse or cross terms until
the derivative of energy with respect to structural perturbation was
less than 5.0 kcal/Aî ; then the method of conjugate gradients, without
Morse or cross terms until the derivative of energy with respect to
structural perturbation was less than 1.0 kcal/Aî ; and ¢nally the meth-
od of conjugate gradients, with Morse and cross terms until the ¢nal
derivative of energy with respect to structural perturbation was less
than 0.1 kcal/Aî .
2.7. Glycoside synthesis
Enzyme (WT, W443C or E432C, 1 mg) was added to a mixed so-
lution (1 ml) of para-nitrophenyl (pNP) L-D-manno-, galacto-, gluco-
and xylo-pyranosides (0.03 mmol of each) in 1:9 MeOH:phosphate
bu¡er (pH 6.5) and incubated at 50‡C for 45 min (WT), 4 h (WT), 8 h
(W433C, E432C). After this time the solutions were extracted with
EtOAc to remove para-nitrophenol and passed through short Sepha-
dex and Celite:Graphite (1:1) columns to remove protein, pNP-glyco-
side and remaining para-nitrophenol. Solvent was removed and prod-
uct mixtures were analysed by 1H nuclear magnetic resonance (NMR)
and ESMS. Yields based on donor were calculated from integration of
anomeric proton resonances in 1H NMR (D2O, 500 MHz): K-Gal (N
5.12, d, J 4.0 Hz), K-Glc (N 5.08, d, J 3.8 Hz), K-xylose (Xyl) (N 5.04,
d, J 3.4 Hz), K-mannose (Man) (N 5.03, d, J 1.8 Hz), L-Man (N 4.75,
s), L-Glc (N 4.49, d, J 8.0 Hz), L-Gal (N 4.45, d, J 7.9 Hz), Me-L-Man
(N 4.44, s), L-Xyl (N 4.42, d, J 7.8 Hz), Me-L-Glc (N 4.23, d, J 8.1 Hz),
Me-L-Xyl (N 4.18, d, J 7.8 Hz), Me-L-Gal (N 4.17, d, J 8.0 Hz).
3. Results and discussion
3.1. Analysis of the 31 binding site of SSLG
In an attempt to dissect the speci¢city determining interac-
tions of SSLG with its substrates we examined the 3D struc-
tures of SSLG (RCSB-PDB 1gow) and the close structural
homologue Bacillus polymyxa L-glycosidase (BPLG). Valua-
bly, 3D structures of BPLG containing D-gluconate bound
as a substrate mimic (1bgg) and a 2-deoxy-2-£uoro-K-D-glu-
Fig. 1. Stereo view of structures indicating the critical binding of substrates in family 1 glycosyl hydrolases (a) BPLG-2-deoxy-2-£uoro-K-D-glu-
copyranosyl enzyme intermediate (1e4i); (b) SSLG (1gow) containing docked and minimised L-D-glucopyranose.
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cosyl-enzyme intermediate (1e4i, Fig. 1a) have recently been
reported. This allowed homology modelling and docking anal-
ysis of SSLG to create a minimum energy structure through
molecular mechanics containing L-D-glucopyranose as a sub-
strate mimic (Fig. 1b). Both the structures of BPLG and SSLG
showed that the conserved (Fig. 2) residues E432 and W433
(SSLG numbering) create vital hydrogen bonds to the OH-4
and -3, respectively, of their substrates (Fig. 1). Furthermore,
M439 sits at the base of the small side pocket that lies in close
proximity to OH-6. Gratifyingly, sequence analysis (Fig. 2)
supports the identi¢cation of the potential of these residues
in speci¢city determination: e.g. S432 (SSLG numbering)
rather than E432 in the phosphogalactosidase (EC 3.2.1.85)
from S. aureus, [39] and G433 rather than W433 in the broad
speci¢city glycosidase/cerebrosidase human lactase phlorizin
hydrolase (EC 3.2.1.62) [37].
We therefore selected E432, W433 and M439 for mutagen-
esis as potentially critical active site residues for determining
substrate speci¢city. Cysteine was chosen as the target residue
for mutations, as a single £exible residue that could play a
variety of roles. C behaves in proteins similarly to W and M
[40], is structurally close to S but would alter some of the key
interactions identi¢ed in Fig. 1 (e.g. abolish hydrogen bond-
ing) in a conservative, informative manner.
Fig. 2. Partial sequence alignment of the 31 binding pocket motif of SSLG [25] with high sequence similarity (left hand column gives SwissProt
or TREMBL annotation, numbering is that of SSLG); glycosidases with similar substrate speci¢city (a) to SSLG and glycosidases with di¡erent
and/or broadened speci¢cities in which E432 (d), W433 (c) and M439 (b^d) di¡er (marked with arrow and highlighted) (D. cochinchinensis L-
glucosidase [35]; C. speciosus furostanol-L-glycoside hydrolase [36]; LPH_HUMAN, human lactase phlorizin hydrolase [37]; MY3_SINAL,
myrosinase [38]; LACG_STAAU (6-PBG), S. aureus 6-phosphogalactosidase [39]).
Table 1
Kinetic parameters for SSLG enzymes at 80‡C, pH 6.5
Substrate Enzyme, SSLG- KM (mM) kcat (s31) kcat/KM (s31 mM31)
4-MUGlc WT 0.046 þ 0.017 140 þ 20 2900
E432C 0.34 þ 0.07 5.1 þ 0.5 15
W433C 1.61 þ 0.35 33 þ 5 20
M439C 0.068 þ 0.028 190 þ 40 2900
4-MUGal WT 0.066 þ 0.017 98 þ 7 1490
E432C 0.47 þ 0.14 5.4 þ 0.8 11
W433C 2.2 þ 1.2 14 þ 6 6.3
M439C 0.083 þ 0.016 94 þ 11 1130
4-MUFuc WT 0.011 þ 0.002 80 þ 2 7300
E432C 0.34 þ 0.04 18 þ 1 53
W433C 0.41 þ 0.09 31 þ 3 76
M439C 0.023 þ 0.005 91 þ 8 4000
4-MUMan WT 0.036 þ 0.009 1.8 þ 0.2 50
E432C 0.90 þ 0.26 2.8 þ 0.7 3.2
W433C 0.18 þ 0.02 0.92 þ 0.05 5.1
M439C 0.042 þ 0.015 2.3 þ 0.4 53
4-MUXyl WT 0.13 þ 0.03 3.8 þ 0.3 30
E432C 1.26 þ 0.21 2.8 þ 0.3 2.2
W433C 0.59 þ 0.19 1.5 þ 0.3 2.5
M439C 0.068 þ 0.007 9.3 þ 0.2 136
4-MUGlcA WT 1.3 þ 0.4 0.81 þ 0.18 0.60
E432C NADa NAD NAD
W433C NAD NAD NAD
M439C 1.4 þ 0.6 1.3 þ 0.4 0.92
aNo activity detected.
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3.2. Construction and kinetic characterisation of WT and
mutant enzymes
SSLG-WT, -E432C, -W433C and -M439C enzymes were
expressed in E. coli as recombinant proteins containing an
N-terminal His6-tag to avoid interfering with the critical mul-
timer-forming interactions of the C-terminus of the protein
[36]. Yields of recombinant protein were of the order of 15
mg per l of culture. The puri¢ed, recombinant WT and mu-
tated SSLG proteins gave single bands on SDS^PAGE at an
indicated approximate molecular weight of 57 000, and gave a
single peak on analysis by gel ¢ltration under non-denaturing
conditions, of an indicated molecular weight consistent with
the formation of dimeric molecules (data not presented). Ex-
act masses were con¢rmed by ESMS ( þ 8 Da). Both WT and
mutant recombinant SSLGs were s 95% pure by these anal-
yses.
Determination of the Michaelis^Menten parameters for the
WT and mutant enzymes was performed at pH 6.5 at 80‡C for
a broad range of representative, £uorophore-containing 4-
MU glycoside substrates, which allowed activities to be deter-
mined with a high degree of sensitivity (Table 1). Under these
optimised assay conditions, the glucoside (Glc), galactoside
(Gal) and fucoside (Fuc) substrates were hydrolysed well by
SSLG-WT, but the xyloside (Xyl) substrate was hydrolysed
relatively poorly (approximately 3% of turnover as determined
by kcat compared with L-D-glucoside). Interestingly, low levels
of previously undetected [30] L-D-mannoside (Man) and L-D-
glucuronide (glucuronic acid, GlcA) activities (approximately
1% and 0.5% of turnover towards L-D-glucoside) were ob-
served. In all cases the absolute D-stereospeci¢city and L-ster-
eoselectivity of SSLG were maintained and no activity was
detected towards L- or K-glycoside substrates.
It is apparent that the E432C and W433C mutations have a
dramatic e¡ect upon activity towards certain substrates. Glc
kcat/KM is reduced 200-fold and 140-fold, and Gal kcat/KM is
reduced 130-fold and 230-fold for E432C and W433C, respec-
tively. However, although Man, Xyl activities were also re-
duced, these reductions were far less marked to kcat/KM values
only 10^16-fold lower than WT for E432C and W433C. Con-
sistent with the prediction from Fig. 1 that hydrogen bonds to
OH-4 (E432C) and OH-3 (W433C) are abolished in these
mutants, these kcat/KM decreases correspond to a loss of af-
¢nity of approximately 4.5^10.5 kJ/mol [41]. These reductions
in kcat/KM were largely manifested in reductions in ground
state binding with KM values generally increased up to 37-
fold; the greatest KM increases in both W433C and E432C
were observed for Glc, Gal, Fuc. Variations in kcat in the
mutants E432C and W433C were less uniform; there were
large overall reductions in Gal, Glc turnover (kcat decreased
by approximately 5^30-fold), whereas kcat values for Fuc, Xyl,
Man in E432C and W433C are essentially similar to those for
SSLG-WT (2-fold increased kcat (Man) for E432C to only 2.9-
fold lowered kcat (Xyl) for W433C). This indicates that an
additional transition state destabilisation is induced by muta-
tion in E432C and W433C that essentially a¡ects Gal, Glc
only.
We were pleased to discover that as a result of the varying
alterations in kcat/KM for di¡erent substrates the speci¢cities
of E432C and W433C were remarkably more broad than
SSLG-WT. For example, the variation of kcat/KM for
Glc:Gal:Xyl:Man moves from a restrictive 100-fold speci¢c-
ity range for WT to a broad 8-fold range for W433C (WT,
100:52:1:2CW433C, 8.1:2.5:1:2).
The M439C mutation has a more subtle e¡ect on speci¢city
than the E432C and W433C mutations. Consistent with the
ability of M439 to modulate substrate C-6 substituent specif-
icity suggested by molecular modelling (Fig. 1b), the level of
kcat/KM alteration caused by mutation di¡ers according to the
C-6 structure. M439C shows almost identical values to WT
for Gal, Glc, Man substrates in which the CH2OH at C-6 is
unaltered. However, kcat/KM for Fuc, which instead bears a
CH3 at C-6, is 1.8-fold lower than WT and excitingly, kcat/KM
for Xyl, which bears no C-6 substituent, is 4.7-fold higher
than WT. It should also be noted that the mutation has the
e¡ect of increasing kcat for all the substrates, suggesting that a
general stabilisation of the transition states is occurring.
It has been proposed previously that in other family 1 gly-
cosidases the position corresponding to E432 in SSLG is re-
sponsible for the modulation of carbohydrate substrate O-6
substituent binding and in particular the rejection of nega-
tively charged substituents [32]. In contrast to this prediction,
the E432C mutant has no detectable activity towards GlcA,
which at pH 6.5 bears a negative charge at C-6. In contrast,
M439C shows slightly enhanced kcat/KM values for GlcA (1.5-
fold higher than WT), also consistent with modulation of C-6
substituent binding by M439.
3.3. Improved biocatalytic breadth of SSLG- and -W433C
Valuably, SSLG-WT’s very high initial activity at 80‡C re-
sulted in enzymes that were still usefully active even after
overall reductions in kcat/KM caused by mutation to E432C
and W433C. For example, W433C displays a kcat/KM towards
L-Gal substrates (6.3 s31 mM31) that compares well with the
activity of recently described enhanced glycosynthases (kcat/
KM 0.013 s31 mM31) [12]. This activity coupled with greatly
broadened speci¢city resulted in a synthetic utility for W433C
Scheme 1. Parallel glycoside syntheses using SSLG-WT, -E432C and
-W433C as catalysts. The corresponding yields of products (each
compound formed is labelled 1^8) are shown in the table. These
show that E432C and W433C mutants of SSLG, in which substrate
speci¢city has been tailored, successfully produced balanced libraries
of the four, desired L-glycosides of Glc (1), Gal (2), Man (3) and
Xyl (4). Such balanced libraries are not produced by SSLG-WT
even under varying reaction times.
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and E432C that was demonstrated by the parallel synthesis of
L-glycosides of Glc, Gal, Xyl, Man within in a one-pot mix-
ture (Scheme 1). SSLG-WT was robust enough to catalyse
transglycosylation at 50‡C in 1:9 MeOH:bu¡er solutions, to
form L-glycosides. However, its stringent speci¢city meant
that after short periods (45 min) only glucoside 1 and galacto-
side 2 were formed and although small amounts of mannoside
3 and xyloside 4 were observed after extended periods (4 h),
by this time all initially formed 1 and 2 had been hydrolysed.
SSLG-WT is therefore incapable of creating libraries of glyco-
sides in this way. We were therefore delighted to ¢nd that
both W433C and E432C yielded mixtures of methyl Glc,
Gal, Xyl, Man glycosides 1^4. Indeed, the tailoring of
E432C’s speci¢city is so successful that it catalyses the forma-
tion of a small library of 1^4 in which each component is
present in near equal amount. This balanced and similar yield
of each of 1^4 mirrors the very similar kcat values (2.8^5.4 s31)
of E432C for Glc, Gal, Xyl, Man substrates, an observation
that is consistent with the high (sKM) concentrations of
substrates used in these reactions.
4. Conclusions
We have succeeded in tailoring the speci¢city of SSLG to
create catalysts of broad synthetic utility. The handful of pre-
vious examples of substrate speci¢city alterations in glycosi-
dases have only involved tailoring towards or away from
functional groups such as CH2OH [18,19] or phosphate [20].
Excitingly, our results suggest that tailoring of stereospeci¢c-
ity is also possible. For example, alteration of a single residue
W433CC e¡ectively broadened the Gal:Man stereospeci¢city
25-fold from 29.4:1 in SSLG-WT to 1.2:1 in SSLG-W433C.
Similarly, in the M439C mutant the sum of speci¢city alter-
ation e¡ects, including a 5-fold absolute increase in Xyl activ-
ity, causes a 10-fold increase in Xyl over Fuc speci¢city. The
power of these mutant enzymes was further demonstrated by
their utility in one-pot parallel syntheses of small arrays of
glycosides that could not be accomplished with WT enzyme.
Further applications of this enhanced synthetic utility includ-
ing their apparent potential in combinatorial biocatalysis are
currently being investigated.
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